The Creso Pharma Ltd (ASX: CPH) share price has continued its strong run and is up 6% to 52 cents in afternoon trade.
This means the medicinal cannabis company's shares have increased over 18% in just the last five trading sessions.
Though, it is worth noting that this gain comes following a series of heavy declines. Even after accounting for recent gains, Creso Pharma's shares have fallen over 25% in the last three months.
The reason for the recent rally appears to be an announcement last week revealing that the company is on track to launch its CannaQix human health nutraceutical product in the first or second quarter of 2018.
The CannaQix product has been designed for the anxiety and stress treatment markets.
Furthermore, the company then plans to expand the range to cover the bone metabolism market by the second quarter of 2019.
